 July 21, 2022 Breda, the Netherlands argenx Euronext Nasdaq: ARGX, a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that it will host a conference call and audio webcast on Thursday, July 28, 2022 at 2:30 pm CET 8:30 am ET to discuss its half year 2022 financial results and provide a second quarter business update. 